Drug Type Fab fragment |
Synonyms Immunoglobulin g1, anti-(human platetet glycoprotein vi) fab fragment (humanized monoclonal act017 .gamma.1-chain), disulfide with humanized monoclonal act017 .kappa.-chain |
Target |
Mechanism GPVI inhibitors(Platelet membrane glycoprotein VI inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Start Date01 Sep 2024 |
Sponsor / Collaborator |
Start Date15 Jan 2024 |
Sponsor / Collaborator |
Start Date23 Sep 2021 |
Sponsor / Collaborator |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Ischemic Stroke | Phase 3 | CN | - | |
Pulmonary Embolism | Phase 2 | FR | - | |
COVID-19 | Phase 1 | FR | 16 Dec 2020 | |
Respiratory Distress Syndrome, Adult | Discovery | FR | 16 Dec 2020 | |
Severe Acute Respiratory Syndrome | Discovery | FR | 16 Dec 2020 | |
SARS-CoV-2 acute respiratory disease | Discovery | BR | 11 Oct 2020 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
Phase 2 | 61 | yanevxuggx(lvqfxwmjso) = awytxywmoz rnpxrfrixx (khgyhtroju ) View more | - | 17 Jun 2024 | |||
Placebo | yanevxuggx(lvqfxwmjso) = hfylmwhmef rnpxrfrixx (khgyhtroju ) View more | ||||||
Phase 1/2 | 166 | (phase 1b) | (uuolgmcojo) = hrellzzore usstccnuda (smbvcjggte ) | Positive | 01 Feb 2024 | ||
Placebo (phase 1b) | - | ||||||
Phase 2 | COVID-19 PCR+ | 61 | rkqmzeztzy(zllyprxgcw) = cjpndpmhhn ihytwfzgtz (umjpdwpkfn ) | Negative | 01 Jan 2024 | ||
Placebo | rkqmzeztzy(zllyprxgcw) = qkmnpbgdci ihytwfzgtz (umjpdwpkfn ) | ||||||
Phase 1/2 | 166 | pyzckjflcx(nbbveadovt) = dgltxcwpkq rwrefkywah (rckfzwadfr ) View more | Positive | 09 May 2022 | |||
Placebo | pyzckjflcx(nbbveadovt) = xkqnsksoyz rwrefkywah (rckfzwadfr ) View more | ||||||
Not Applicable | - | ifwsdqwbzx(zhgdkolgma) = mfidoqphqo mlqduhbsmo (ixucibmjvj ) View more | - | 28 Aug 2021 | |||
ifwsdqwbzx(zhgdkolgma) = ihiwqtlozl mlqduhbsmo (ixucibmjvj ) View more |